Preclinical PK/PD model for combined administration of erlotinib and sunitinib in the treatment of A549 human NSCLC xenograft mice. [electronic resource]
Producer: 20170802Description: 930-40 p. digitalISSN:- 1745-7254
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- pharmacokinetics
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Computer Simulation
- Drug Dosage Calculations
- Drug Synergism
- Erlotinib Hydrochloride -- pharmacokinetics
- Female
- Indoles -- pharmacokinetics
- Lung Neoplasms -- drug therapy
- Mice
- Mice, Nude
- Models, Biological
- Pyrroles -- pharmacokinetics
- Sunitinib
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.